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Cyanobacteria are among the most ancient forms of life, yet they are known to synthesize 
highly sophisticated defense molecules, such as the highly hepatotoxic cyclic peptides microcystins 
and nodularins produced by the genera Microcystis, Anabaena and Nodularia. These metabolites 
are released by cyanobacteria to water environments causing episodes of fatalities among animals 
and humans. To better understand the releasing of these metabolites, imaging mass spectrometry 
(IMS) using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) was herein 
applied to determine the spatial distribution of such toxins directly on agar-based cultures. Other 
key metabolites such as aeruginosin 602 and the siderophore anachelin were also mapped in mixed 
cyanobacterial cultures, showing the great potential of IMS to spatially monitor the biochemical 
details of cyanobacterial defense and interactions.
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Introduction
Cyanobacteria are believed to represent one of the 
most ancient yet highly sophisticated forms of life1 and 
these gram-negative oxygenic photosynthetic autotrophic 
microorganisms are adapted to various ecological habitats 
such as fresh water, marine, brackish, glaciers, and terrestrial 
environments.2 Fresh and brackish water cyanobacteria 
are known to produce a diversity of highly elaborated 
secondary metabolites, with a truly fascinating variety 
of structures that exhibit a broad range of applications 
in the food, nutritional, cosmetic, pharmaceutical and 
nutraceutical industries.3
Bloom-forming cyanobacteria (Figure 1), for instance, 
such as Microcystis aeruginosa, Anabaena cylindrica and 
Nodularia harveyana, are known to produce a variety of 
bioactive metabolites.
Among these metabolites, cyclic and linear peptides such 
as microcystin, nodularin, aeruginosin, anabaenopeptin, 
cyanopeptolin, microginin, cyclamides and microviridin 
Figure 1. Optical microscope images (100×) of the cyanobacteria Microcystis aeruginosa PCC 7820, Anabaena cylindrica PCC 7122 and Nodularia 
harveyana PCC 7804.
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are found, which show activity against various proteases 
or protein phosphatases.4 Most of these potent and 
“dangerous” peptides are released by the cyanobacteria 
cells into the environment and numerous cases of 
cyanobacteria poisoning in animals and humans have been 
reported worldwide.5 Some cyanobacteria also produce 
iron chelators known as siderophores such as anachelin, 
schizokinen and synechobactin.6
There is an interesting behavior of these metabolites, 
among which the cyclic peptides microcystins and 
nodularins are such that they are retained inside the cell 
membrane, whereas anachelin finds its way out in the form 
of a siderophore, which passes through the membrane into 
and out of the cell.
Mass spectrometry (MS) and mainly matrix-
assisted laser desorption ionization-mass spectrometry 
(MALDI-MS) has grown tremendously as a powerful 
tool to analyze secondary metabolites of microorganisms7 
and other species such as virus,8 bacteria9 and embryos.10 
MALDI-MS has also been demonstrated to offer a suitable 
technique for the analysis of cyanobacteria metabolites and 
cyanobacteria extracts.11
Imaging mass spectrometry (IMS) that incorporates 
spatial distribution is an emerging and promising 
new technology for metabolomics MS analysis. This 
methodology was introduced in 1997 by Caprioli et al.12 
and mostly applied to create 2D images based on the spatial 
distribution of peptides and protein across the surface of 
intact biological tissues. MALDI-IMS combines the high 
sensitivity and selectivity of MS with 2D surface screening 
analysis, and its scope has been expanded to deliver spatial 
distributions of several biomolecules such as metabolites 
and lipids in different biological matrices.13 This technique 
has also been applied for analysis of microbial natural 
products,14 microbial interactions15 and metabolic profiling 
of microorganisms.16 Recently, MALDI-IMS has been 
tested for filamentous marine cyanobacteria,17 showing the 
spatial distribution of natural products. The main challenges 
in MALDI-IMS are the sample preparation and the spatial 
resolution. The sample preparation protocol needs to be 
selected carefully because an inappropriate application 
of the matrix may lead to the loss of information of the 
section analyzed. But the spatial resolution achieved to date 
is about 10 μm, far from the typical diameter of bacterial 
cells which lies between 0.2 and 2.0 μm.18
We report herein an investigation of the suitability 
of MALDI-IMS to visualize the spatial distributions of 
hepatotoxic cyclic peptides and other key metabolites, and 
hence to monitor the chemical dynamics of the interactions 
in cultures and mixed cultures of fresh water cyanobacteria 
directly on agar plates.
Experimental
Cyanobacteria cultures
The cyanobacteria cultures Microcystis aeruginosa 
PCC 7820, Nodularia harveyana PCC 7804 and 
Anabaena cylindrica PCC 7122 were provided by The 
Pasteur Culture collection of Cyanobacteria (PCC), France.
The species Microcystis aeruginosa PCC 7820 and 
Nodularia harveyana PCC 7804 were grown in 1.0 L 
Fernbach flasks containing 0.5 L of modified BG-11 
medium, BG-110 (BG-11 medium without nitrate) + 
NaNO3 (2.0 mmol L-1) + NaHCO3 (10.0 mmol L-1). The 
cyanobacteria Anabaena cylindrica PCC 7122 was grown 
in BG-110 medium. All strains were maintained at 25 °C 
at a photon flux density of approximately 5.0 μmol m-2 s-1 
and a regime of 12 h light/12 h dark.
Sample preparation
Cyanobacterial MALDI-IMS sample preparation 
workflow (Scheme 1) starts with the addition of 10.0 mL of 
agar media over the Petri dish with glass slide for MALDI 
imaging inside. The agar is 1.0 to 1.5 mm thick; with the 
final concentration of 0.6% and for these experiments we 
used the modified BG-11 medium. Afterwards, 50.0 μL 
of cyanobacteria culture was inoculated on agar-based 
medium directly on top of the MALDI glass slide and 
spread with the inoculation loop.
The Petri dishes were sealed with Parafilm M® and 
placed in a germination chamber with photoperiod, 
TECNAL TE-401, at 25 °C at a photon flux density of 
approximately 5.0 μmol m-2 s-1 and a regime of 12 h 
light/12 h dark for three weeks. After this, the culturing 
glass slide was removed by cutting the surrounding with 
scalpel. Using a TLC sprayer flask, the saturated solution 
of α-cyano-4-hydroxycinnamic acid was spread over the 
glass slide with the microbial culture, after that, it was put 
in a desiccator with vacuum for 20 minutes. The prepared 
glass slide was put on a target for MALDI imaging with 
two conductive-surface microscope slides.
MALDI imaging
The MALDI imaging was performed using an 
Autoflex III MALDI-TOF/TOF (Bruker Daltonics, 
Germany) equipped with smartbeam (337 nm) laser 
desorption imaging ion source in the positive ion mode. 
The MALDI imaging experiments were controlled 
by the program FlexImaging 3.0 (Bruker Daltonics, 
Germany). The laser diameter was set to ca. 100 μm and 
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rastered along the x- and y-axis of selected regions at 
200 μm resolution. Each spectrum was acquired from 
500 laser shots on a single spot. The range over which 
ions were detected was m/z 500 to 2200. The laser 
power range was adjusted to 50-70% before the imaging 
experiment to yield optimal results. MALDI imaging 
measurements were done in operating conditions as 
follows: ion source 1 = 19.00 kV, ion source 2 = 16.6 kV, 
lens voltage = 8.50 kV, reflector voltage 1 = 21.00 kV, 
reflector voltage 2 = 9.70 kV, pulsed ion extraction 
time = 120 ns, and suppression = 500 Da. Images were 
created and normalized using the FlexImaging software.
Results and Discussion
Scheme 1 shows the MALDI-IMS workflow used. 
The first step was the preparation of a glass slide for 
MALDI-IMS with the agar medium and the inoculation 
of cyanobacteria. After three weeks, the culture was ready 
and the glass slide was removed from the Petri dish and 
setup for the MALDI-IMS experiment.
As a test case, we studied the cyanobacteria 
Microcystis aeruginosa PCC 7820, which was selected due to 
its high ecological and economic relevance since it is known to 
form quite harmful blooms.19 Figure 2a shows the glass slide 
with the M. aeruginosa PCC 7820 colonies. The red rectangle 
shows the area to which the α-cyano-4-hydroxycinnamic 
acid matrix was applied for MALDI-IMS monitoring.
Many ions of m/z ranging from 550 to 1500 with 
contrasting spatial distributions were detected and their 
images, as Figure 2 illustrates. Some of these ions were 
identified as variants of the aeruginogins and microcystin 
toxins. The linear peptide aeruginosin 602 (Figure 3) 
was detected as its protonated molecule of m/z 603.3 and 
Figure 2b shows its spatial distribution as revealed by 
MALDI-IMS. Comparing the morphology of the colonies 
(Figure 2a) with the IMS of Figure 2b, it is clear that 
aeruginosin 602 (m/z 603.3) is secreted by the colonies 
spreading all over their surroundings.
The cyanobacteria M. aeruginosa PCC 7820 is known 
to produce several hepatotoxic cyclic heptapeptide 
microcystins, mainly the variants microcystin-LR (MC-LR) 
and the [D-Asp3]-microcystin-LR ([D-Asp3]-MC-LR), 
Figure 4.20 Indeed, as Figure 2c shows, the IMS detects an 
ion of m/z 995.6 related to microcystin-LR (MC-LR), which 
is found in greater abundance inside the colonies. This IMS 
data perfectly reflects what is known for such peptide, that 
it has been reported to be unable to pass through the cell 
membrane being secreted to the environment.6
The relative abundances of the microcystins variants 
MC-LR (m/z 995.6) and [D-Asp3]-MC-LR (m/z 981.5) 
could also be monitored by MALDI-IMS (Figure 5). 
MC-LR was detected over the three colonies, whereas 
the [D-Asp3]-MC-LR peptide was clearly much more 
abundant on the left colony. This spatial distribution is in 
agreement with the microcystins variants produced by the 
cyanobacteria M. aeruginosa PCC 7820 in which MC-LR 
is known to largely dominate over [D-Asp3]-MC-LR.20
Figure 6 shows the IMS for another colony of 
M. aeruginosa PCC 7820, where a similar spatial distribution 
Scheme 1. Cyanobacteria MALDI-IMS workflow.
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pattern for the ions of m/z 603.3 (aeruginosin 602) and 
m/z 995.6 (MC-LR) is exhibited. That is, aeruginosin 602 
(Figure 6b) spreads all over the colony and its surroundings 
whereas MC-LR resides inside the colony (Figure 6c).
The interactions between two different species of 
cyanobacteria, that is, Nodularia harveyana PCC 7804, 
which produces the hepatotoxic cyclic pentapeptides 
nodularins (Figure 7),21 and the Anabaena cylindrica 
PCC 7122, which was selected for being a nontoxic strain 
that produces the linear peptide siderophore anachelin 
(Figure 8), were also monitored by IMS.22
Figure 9a shows the glass slide for the cyanobacteria 
cultures on an agar plate, inoculated on the right side with 
the N. harveyana PCC 7804 strain and on the left side 
the A. cylindrica PCC 7122 strain. Note in Figure 9b that 
IMS reveals that the siderophore anachelin (m/z 761.3) is 
spread all over the slide except over the area occupied by 
the colony of N. harveyana PCC 7804. This result agrees 
with the properties of anachelin because it is known to 
be released by the cells of A. cylindrica PCC 7122 and to 
diffuse on agar.22
Figure 2. MALDI-IMS of colonies of Microcystis aeruginosa PCC 7820. (a) Scanned area highlighted via a red rectangle; (b) image generated by 
monitoring the ion of m/z 603, corresponding to the protonated molecule of the linear peptide aeruginosin 602; (c) image obtained for the ion of m/z 995, 
corresponding to the spatial distribution of MC-LR.
Figure 3. Structure of linear peptide aeruginosin 602.
Figure 4. Structures of microcystin variants: (a) microcystin-LR (MC-LR) 
and (b) [D-Asp3]-microcystin-LR.
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Figure 5. MALDI-IMS images for microcystins variants of Microcystis aeruginosa PCC 7820: (a) microcystin-LR (m/z 995.6) and (b) [D-Asp3]-
microcystin-LR (m/z 981.5).
Figure 6. MALDI-IMS images for colonies of Microcystis aeruginosa PCC 7820 with the scanned area (a). Images of (b) linear peptide aeruginosin 602 
(m/z 603.3) and (c) cyclicpeptide microcystin-LR (m/z 995.6).
Figure 7. Structures of nodularin variants: nodularin-R (Nod-R) and nodularin-[Har] (Nod-[Har]).
Figure 8. Structure of siderophore anachelin.
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Figures 9c and 9d show the MALDI-IMS for 
nodularin-R (Nod-R, m/z 825.5) and nodularin-[Har] 
(Nod-[Har], m/z 839.5), respectively. Note that these 
nodularins show the same behavior as the microcystins, 
being in greater abundances inside the colonies of the 
N. harveyana PCC 7804.
Next, a culture on agar of three cyanobacteria species 
with the N. harveyana PCC 7804 inoculated on the left 
side, the M. aeruginosa PCC 7820 inoculated on the 
center and the A. cylindrica PCC 7122 inoculated on the 
right side, was subjected to MALDI-IMS (Figure 10). 
Characteristic ions for each species were monitored, that 
is, the nodularin Nod-[Har] biomarker of m/z 839.5 in red 
for the N. harveyana PCC 7804, the microcystins MC-LR 
of m/z 995.6 in blue for M. aeruginosa PCC 7820 and the 
anachelin of m/z 761.3 in green for A. cylindrica PCC 7122. 
Note in Figure 10a that the selection of such biomarker 
ions allows IMS to properly draw morphologically precise 
shapes of each respective colony. Note that anachelin 
(m/z 761.3) is indeed exclusive for the colonies of the 
Anabaena cylindrica PCC 7122. Note also that the ions of 
m/z 619.1 (Figure 10b), 1643.6 (Figure 10f) and 1971.5 
(Figure 10g) are in greater abundance between colonies and, 
therefore, related to “cross talking”.14,15,22 The ion of m/z 
638.5 (Figure 10c) is, however, in greater abundance only 
on the colonies of the N. harveyana PCC 7804. The ion of 
m/z 989.4 (Figure 10d) is detected in all the three colonies, 
whereas that of m/z 1276.3 (Figure 10e) is abundant except 
for the colonies of the M. aeruginosa PCC 7820.
Conclusions
Selective MALDI-IMS of fresh water cyanobacteria 
cultures was obtained directly from agar culture with 
sufficient sensitivity and conserved spatial distribution. 
Characteristic 2D profiles revealed details of the 
dynamics of peptide distribution within the colony and 
between colonies of the different species. Distribution 
of biomolecules related to the “cross talking” process 
could also be detected on the boundaries between 
the colonies.
These chemically selective images obtained directly 
from agar cultures on prototype fresh water cyanobacteria 
indicate that is an important tool and can be used to 
understand the releasing dynamics of toxic peptide by 
cyanobacteria to the environment, as well as in their 
defense during cross talking processes involving secondary 
metabolites.
Figure 9. MALDI-IMS of colonies of N. harveyana PCC 7804 and A. Cylindrica PCC 7122. (a) The scanned area is highlighted via a red rectangle and images 
for (b) the siderophore anachelin (m/z 761); (c) the cyclic peptide nodularin-R (m/z 825) and (d) the cyclic peptide nodularin-[Har] (m/z 839) are shown.
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Figure 10. MALDI-IMS images for three cyanobacteria species N. harveyana PCC 7804, M. aeruginosa PCC 7820 and A. cylindrica PCC 7122. (a) Images 
for the biomarkers nodularin Nod-[Har] (m/z 839.5), microcystins MC-LR (m/z 995.6) and anachelin (m/z 761.3); (b) to (g): images for the unknown ions 
m/z 619.1, 638.5, 989.4, 1276.3, 1643.6 and 1971.5.
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